glutathione small cell lung cancer

glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small Glutathione depletion based Pt(IV) hybrid

Name: glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small Glutathione depletion based Pt(IV) hybrid
Brand: eduardorossin.com.br
SKU: 95588036724
Price: 28.66 USD
Availability: InStock
Rating: 4.2511 (18 reviews)

Glutathione depletion based Pt(IV) hybrid mesoporous organosilica delivery system to conquer cisplatin chemoresistance: A one stone three birds strategy ScienceDirect The Rockefeller University Mitochondrial antioxidant found to drive breast cancer metastasis The crosstalk between glutathione metabolism and non coding RNAs in cancer progression and treatment resistance ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies glutathione platinum resistance A cisplatin based platinum(IV) prodrug containing a s transferase inhibitor to reverse cisplatin resistance in

SKU: 95588036724 · From eduardorossin.com.br

4.3

USD28.66 USD52.66

Pay in 4 interest-free payments of $7.17 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

New work demonstrates how one antioxidant inside particular cellular compartments, the mitochondrial metabolite glutathione, helps cancer cells metastasize throughout the body by enabling their survival under low-oxygen conditions